According to the evening report of the channel 11 is expected this Sunday the government to approve the final export of medical cannabis abroad. The disagreements on the matter will apparently be resolved about two months after the prime minister froze the move. However, the export process will apparently begin in a few months and depends on several factors.
* updating (12.4 - 09: 30): The announcement of the expected confirmation of the export was probably premature too. The promised hearing for Sunday Does not appear Government schedule for next week.
Cannabis Medical Reform is beginning to take shape in the coming weeks. Which was revealed In Cannabis magazine for the first time.
What cast a heavy shadow on the plan was the freezing of the decision to approve the export of cannabis abroad, without which there is no economic justification for the establishment of dozens and hundreds of new businesses in the field.
This evening (Monday), Channel 11 correspondent Shaul Amsterdsky reports that next Sunday the government is expected to approve exports, following understandings between the Ministry of Finance and the Ministry of Public Security.
Within the framework of the agreements, the Ministry of Internal Security will receive an addition to the enforcement of the medical cannabis branch to ensure that there is no leakage of the material into the leisure market, as well as additional increased budgets as the quantities of cannabis exported abroad increase.
Two months ago, Prime Minister Benjamin Netanyahu froze the approval of exports after meeting cabinet ministers. He was presented with complaints from Minister Gilad Erdan that there were alleged criminal elements involved in the area and that there was a real fear of leakage.
Since then rumors have circulated that US President Donald Trump has ordered Netanyahu not to approve exports, but they have been refuted by industry experts who now seem to have been right.
However, even if it is approved on Sunday, it does not mean that medical cannabis packets will be sent abroad, as the cannabis transfer procedure, which is considered a dangerous drug by law, must be regulated through customs authorities, airports and in coordination with the importing countries.
In addition, a number of times have been reported to confirm the expected export of "next week", without a real basis - so it is quite likely that in this case too it turns out the report is not accurate.
Those who are waiting eagerly for export approval are the cannabis companies traded on the stock exchange, which is expected to increase their value, even though some of them As we have shown Are not yet ready for activity in the field.
It should be noted that in order to export medical cannabis abroad it is necessary that the raw material from which the cannabis products were produced was grown in farms that have IMC-GAP approval, Only by one company. It is also required that the products be manufactured in factories that have the IMC-GMP standard and currently have Only one factory Who meets this condition.